Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kyverna Therapeutics
KYTX
$473M
| $1.03M | ﹤0.01% |
274,414
+39,291
| +17% | +$188K |
|
1627
IDEAYA Biosciences
IDYA
$3.48B
| $1.02M | ﹤0.01% |
39,790
-2,321
| -6% | -$65.7K |
|
1628
Acadia Pharmaceuticals
ACAD
$4.65B
| $1.02M | ﹤0.01% |
55,712
-6,873
| -11% | -$111K |
|
1629
C4 Therapeutics
CCCC
$399M
| $1.02M | ﹤0.01% |
283,705
-2,336
| -0.8% | -$11.6K |
|
1630
PUT
German American Bancorp
GABC
$1.92B
| $1.01M | ﹤0.01% |
+520,000
| New | +$22M |
|
1631
Taysha Gene Therapies
TSHA
$1.78B
| $1.01M | ﹤0.01% |
585,594
+122,402
| +26% | +$254K |
|
1632
Duolingo
DUOL
$6.42B
| $1.01M | ﹤0.01% |
3,115
-7,178
| -70% | -$2.28M |
|
1633
Rivian
RIVN
$22.8B
| $992K | ﹤0.01% |
74,568
+39,668
| +114% | +$457K |
|
1634
4D Molecular Therapeutics
FDMT
$536M
| $987K | ﹤0.01% |
177,279
+11,089
| +7% | +$87K |
|
1635
State Street SPDR S&P International Small Cap ETF
GWX
$894M
| $975K | ﹤0.01% |
31,468
-5,539
| -15% | -$179K |
|
1636
Vodafone
VOD
$36.3B
| $970K | ﹤0.01% |
+114,300
| New | +$1.04M |
|
1637
Macy's
M
$6.89B
| $959K | ﹤0.01% |
56,637
-2,004,365
| -97% | -$31.9M |
|
1638
Virtu Financial
VIRT
$5.03B
| $954K | ﹤0.01% |
+26,751
| New | +$920K |
|
1639
Akebia Therapeutics
AKBA
$354M
| $954K | ﹤0.01% |
502,127
+97,409
| +24% | +$169K |
|
1640
LiveRamp
RAMP
$2.3B
| $951K | ﹤0.01% |
31,306
| – | – |
|
|
CURB
1641
Curbline Properties
CURB
$3.46B
| $948K | ﹤0.01% |
+40,809
| New | +$960K |
|
1642
Absci
ABSI
$1.44B
| $924K | ﹤0.01% |
352,805
+3,951
| +1% | +$13.9K |
|
|
EBTC
1643
DELISTED
Enterprise Bancorp
EBTC
| $923K | ﹤0.01% |
23,333
-40,590
| -63% | -$1.46M |
|
1644
MeiraGTx Holdings
MGTX
$1.14B
| $920K | ﹤0.01% |
151,126
+1,379
| +0.9% | +$8.08K |
|
1645
PUT
Suncor Energy
SU
$76.1B
| $914K | ﹤0.01% |
5,425
| – | – |
|
|
CNCK
1646
Coincheck Group
CNCK
$420M
| $911K | ﹤0.01% |
+102,451
| New | +$976K |
|
1647
Dyne Therapeutics
DYN
$4.85B
| $908K | ﹤0.01% |
38,550
-3,111
| -7% | -$92K |
|
1648
PUT
ARK Innovation ETF
ARKK
$6.09B
| $908K | ﹤0.01% |
+5,377
| New | +$288K |
|
1649
Descartes Systems
DSGX
$6.63B
| $904K | ﹤0.01% |
7,957
+438
| +6% | +$48.8K |
|
|
JNPR
1650
DELISTED
Juniper Networks
JNPR
| $887K | ﹤0.01% |
23,672
+1,852
| +8% | +$70.1K |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.